Genetics of aldosterone-producing adenomas with pathogenic KCNJ5 variants.


Journal

Endocrine-related cancer
ISSN: 1479-6821
Titre abrégé: Endocr Relat Cancer
Pays: England
ID NLM: 9436481

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 08 08 2018
accepted: 11 02 2019
entrez: 13 2 2019
pubmed: 13 2 2019
medline: 18 3 2020
Statut: ppublish

Résumé

Somatic variants in genes that regulate intracellular ion homeostasis have been identified in aldosterone-producing adenomas (APA). Although the mechanisms leading to an increased aldosterone production in APA cells has been well studied, the molecular events that cause cell proliferation and tumor formation are poorly understood. In the present study, we have performed whole exome sequencing (WES) to characterize the landscape of somatic alterations in a homogeneous series of APA with pathogenic KCNJ5 variants. In the WES analysis on eleven APA, 84 exonic somatic events were called by 3 different somatic callers. Besides the KCNJ5 gene, only two genes (MED13 and ZNF669) harbored somatic variants in more than one APA. Unlike adrenocortical carcinomas, no chromosomal instability was observed by the somatic copy-number alteration and loss of heterozygosity analyses. The estimated tumor purity ranged from 0.35 to 0.67, suggesting a significant proportion of normal cell infiltration. Based on the results of PureCN analysis, the KCNJ5 variants appear to be clonal. In conclusion, in addition to KCNJ5 somatic pathogenic variant, no significant somatic event that would obviously explain proliferation or tumor growth was observed in our homogeneous cohort of KCNJ5-mutated APA. The molecular mechanisms causing APA growth and tumorigenesis remain to be elucidated.

Identifiants

pubmed: 30753137
doi: 10.1530/ERC-18-0364
pii: ERC-18-0364
pmc: PMC7869655
mid: NIHMS1575539
doi:
pii:

Substances chimiques

G Protein-Coupled Inwardly-Rectifying Potassium Channels 0
KCNJ5 protein, human 0
Aldosterone 4964P6T9RB

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

463-470

Subventions

Organisme : NCI NIH HHS
ID : P30 CA046592
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK106618
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL130106
Pays : United States

Références

Sci Rep. 2016 Jan 27;6:19546
pubmed: 26815163
Nat Rev Cancer. 2004 Mar;4(3):177-83
pubmed: 14993899
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Bioinformatics. 2016 Jan 15;32(2):292-4
pubmed: 26428292
Cancer Res. 2005 Sep 1;65(17):7622-7
pubmed: 16140927
J Clin Endocrinol Metab. 2016 May;101(5):1889-916
pubmed: 26934393
J Clin Endocrinol Metab. 2014 Jul;99(7):E1341-51
pubmed: 24758183
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Hypertension. 2012 Feb;59(2):235-40
pubmed: 22203740
Endocrinology. 2012 Apr;153(4):1774-82
pubmed: 22315453
Bioinformatics. 2011 Aug 1;27(15):2156-8
pubmed: 21653522
J Clin Endocrinol Metab. 2016 Mar;101(3):999-1007
pubmed: 26765578
Nucleic Acids Res. 2012 Dec;40(22):11189-201
pubmed: 23066108
Clin Endocrinol (Oxf). 2007 May;66(5):607-18
pubmed: 17492946
J Clin Endocrinol Metab. 2012 May;97(5):E819-29
pubmed: 22442279
Mol Cell Endocrinol. 2015 Aug 15;411:146-54
pubmed: 25958045
Hum Mol Genet. 2014 Feb 15;23(4):889-905
pubmed: 24087794
Biol Reprod. 2004 Jul;71(1):83-8
pubmed: 14985252
Source Code Biol Med. 2016 Dec 15;11:13
pubmed: 27999612
Crit Rev Biochem Mol Biol. 2015;50(5):393-426
pubmed: 26182352
Cancer Cell. 2016 May 9;29(5):723-736
pubmed: 27165744
Endocr Rev. 2017 Dec 1;38(6):516-537
pubmed: 28973103
Mol Cell Endocrinol. 2017 Feb 5;441:134-139
pubmed: 27514282
Hypertension. 2010 Nov;56(5):885-92
pubmed: 20937967
Endocrinology. 2011 Dec;152(12):4753-63
pubmed: 21971159
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Science. 2011 Feb 11;331(6018):768-72
pubmed: 21311022
J Clin Endocrinol Metab. 2016 Nov;101(11):3874-3878
pubmed: 27648962
Mol Cell Endocrinol. 2014 Jul 5;392(1-2):73-9
pubmed: 24837548
Am J Surg Pathol. 2018 Feb;42(2):201-213
pubmed: 28877067
Nat Genet. 2014 Jun;46(6):613-7
pubmed: 24747643
J Clin Endocrinol Metab. 2012 Aug;97(8):E1567-72
pubmed: 22628608
Steroids. 2017 Nov;127:56-61
pubmed: 28863887
Commun Biol. 2018 Mar 22;1:20
pubmed: 30271907
Mol Cell Endocrinol. 2014 Mar 5;383(1-2):111-7
pubmed: 24325867
Eur J Endocrinol. 2015 Aug;173(2):185-95
pubmed: 25953827
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2533-8
pubmed: 22308486
Sci Rep. 2017 Jan 19;7:39121
pubmed: 28102204
Nucleic Acids Res. 2017 Jun 20;45(11):e103
pubmed: 28369524
Eur J Endocrinol. 2018 Mar;178(3):R101-R111
pubmed: 29348113
Hypertension. 2015 Nov;66(5):1014-22
pubmed: 26351028

Auteurs

Antonio M Lerario (AM)

Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.

Kazutaka Nanba (K)

Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.

Amy R Blinder (AR)

Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.

Sachiko Suematsu (S)

Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan.

Masao Omura (M)

Medical Checkup Clinic, Minatomirai Medical Square, Sowa-Group, Yokohama, Japan.

Tetsuo Nishikawa (T)

Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan.

Thomas J Giordano (TJ)

Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.

William E Rainey (WE)

Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.

Tobias Else (T)

Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH